NEW YORK, Sept. 15, 2023 /PRNewswire/ — The 3D cell culture market size is expected to grow by USD 1.28 billion from 2021 to 2026. In addition, the momentum of the market will be progressing at a CAGR of 15.69% during the forecast period, according to Technavio Research. The market is segmented by application (Cancer and stem cell research, Drug discovery and toxicology testing, and Tissue engineering and regenerative medicine) and geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to account for 41% of the global market during the forecast period. The primary markets for 3D cell culture in North America are the US and Canada. In this region, market growth is expected to outpace that in Europe and the Rest of the World (ROW). This accelerated growth can be attributed to substantial investments in new manufacturing facilities made by major companies like Becton, Dickinson, and Company, Corning Incorporated, and Thermo Fisher Scientific Inc. Such investments are set to drive the expansion of the 3D cell culture market in North America during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read FREE PDF Sample Report
Company Profile:
3D Biotek LLC, BICO Group AB, CN Bio Innovations Ltd., Corning Inc., Elveflow, Emulate Inc., Greiner Bio-One International GmbH, Hamilton Bonaduz AG, InSphero AG, Lonza Group Ltd., Merck KGaA, PromoCell GmbH, QGel SA, REPROCELL Inc., Synthecon Inc., SynVivo Inc., Tecan Group Ltd., Thermo Fisher Scientific Inc., TissUse GmbH, and MIMETAS BV
3D Biotek LLC – The company offers 3D Cell Culture products such as 3D cell culture devices.
To gain access to more vendor profiles available with Technavio, buy the report!
3D Cell Culture Market: Segmentation Analysis
The market is segmented by application (Cancer and stem cell research, Drug discovery and toxicology testing, and Tissue engineering and regenerative medicine) and geography (North America, Europe, Asia, and Rest of World (ROW)).
- The 3D cell culture market share growth by cancer and stem cell research segment will be significant during the forecast period. The rising prevalence of cancer and significant funding for cancer research are significant factors that are anticipated to drive the growth of the segment in focus during the forecast period.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
3D Cell Culture Market: Driver & Trend:
The increase in infectious diseases is notably driving the market growth.
Identify key trends, drivers, and challenges in the market. Download FREE sample to gain access to this information.
What are the key data covered in this 3D cell culture market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the 3D cell culture market between 2021 and 2026.
- Precise estimation of the 3D cell culture market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the 3D cell culture market in North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of 3D cell culture market vendors.
Related Reports:
The Global Cell Culture Market size is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The size of the market is forecasted to increase by USD 17.74 billion. The report extensively covers market segmentation by product (consumables and equipment), end-user (pharma and biotech companies, hospitals, research and academic institutes, and others), and geography (North America, Europe, Asia, and Rest of World). Market growth is being driven by the significant potential in emerging regions, notably India, China, and South Africa.
The cell culture consumables market size is estimated to grow at a CAGR of 22.3% between 2022 and 2027. The size of the cell culture market is forecast to increase by USD 23,729.7 million. This market report extensively covers market segmentation by application (biopharmaceutical production, cancer research, and others) and geography (North America, Europe, Asia, and Rest of World). The growing demand for monoclonal antibodies is notably driving market growth.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-cell-culture-market-to-grow-by-usd-1-28-billion-from-2021-to-2026–north-america-to-account-for-41-of-market-growth–technavio-301928472.html
SOURCE Technavio
Featured image: Megapixl © Prometeus